INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 215 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$77,000
-23.0%
10,7370.0%0.01%
-22.2%
Q2 2021$100,000
-54.3%
10,737
-55.4%
0.02%
-10.0%
Q1 2021$219,000
+128.1%
24,064
+121.6%
0.02%
+17.6%
Q4 2020$96,000
-70.2%
10,857
-9.3%
0.02%
-77.9%
Q2 2020$322,000
+323.7%
11,965
+17.3%
0.08%
+234.8%
Q1 2020$76,00010,2000.02%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders